Marquis® Paste (Rx) - Single Tube


Note: Availability varies. Contact us to inquire status.

Marquis® (15% w/w ponazuril) Antiprotozoal Oral Paste

First FDA-approved treatment for equine protozoal myeloencephalitis (EPM). is indicated as an aid in reducing the clinical severity of Equine Protozoal Myeloencephalitis (EPM) caused by Sarcocystis neurona in horses; it is expected that approximately two horses out of three will respond favourably to treatment. One 127 g syringe ONLY.

This product is not eligible for any discounts.

More Information
Item 22-2201